← Back to Search

Behavioral Intervention

CuidaTXT for Caregiver Burnout (CuidaTXT Trial)

Phase 1
Waitlist Available
Research Sponsored by University of Kansas Medical Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months from baseline
Awards & highlights

Summary

This trial will develop a text message intervention to support caregivers of Latinos with dementia, who are at increased risk for negative outcomes without support.

Eligible Conditions
  • Caregiver Burnout

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months from baseline
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months from baseline for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Average of the Percentage of Messages Sent by Each Participant to Interact With the Intervention That Were Keywords
Number of Participants Who Reported Experiencing Technical Problems With the Intervention
Percentage of Participants Able to Opt Into CuidaTXT (Enrollment Feasibility)
+4 more
Secondary study objectives
Alzheimer's Disease
Mental Depression
Change From Baseline to 6 Months in Caregiver Social Support
+1 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: CuidaTXTExperimental Treatment1 Intervention
This intervention, CuidaTXT \[Spanish for self-care and texting\], will be available in English and Spanish, incorporate two-way messaging and will tailor text messages to the preferences of Latino caregivers. CuidaTXT will be multicomponent and based on the Stress Process Framework as supported by evidence. The intervention will incorporate social support and coping components including dementia education, problem-solving skills training, social network support, care management and referral to community resources.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
CuidaTXT
2021
Completed Phase 1
~30

Find a Location

Logistics

Participation is compensated

You will be compensated for participating in this trial.

Who is running the clinical trial?

University of Kansas Medical CenterLead Sponsor
488 Previous Clinical Trials
172,431 Total Patients Enrolled
National Institute on Aging (NIA)NIH
1,733 Previous Clinical Trials
28,054,979 Total Patients Enrolled
~6 spots leftby Sep 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top